Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $411,600.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00. Following the completion of the transaction, the president now directly owns 1,576,097 shares of the company’s stock, valued at approximately $21,624,050.84. This trade represents a 1.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Down 8.4 %

Shares of NASDAQ ALHC opened at $13.17 on Friday. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $15.82. The firm’s 50 day moving average price is $13.19 and its 200 day moving average price is $11.76. The firm has a market cap of $2.52 billion, a P/E ratio of -17.10 and a beta of 1.50. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Analyst Ratings Changes

ALHC has been the subject of a number of recent research reports. Stifel Nicolaus raised their price objective on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Tuesday, January 14th. Stephens reissued an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a research note on Thursday, January 2nd. Barclays raised their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 30th. Finally, UBS Group raised their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $11.88.

Institutional Trading of Alignment Healthcare

Hedge funds have recently bought and sold shares of the company. R Squared Ltd acquired a new stake in Alignment Healthcare during the fourth quarter worth approximately $55,000. RiverPark Advisors LLC acquired a new position in shares of Alignment Healthcare in the 4th quarter valued at $106,000. Tower Research Capital LLC TRC boosted its holdings in shares of Alignment Healthcare by 146.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock valued at $119,000 after purchasing an additional 6,286 shares during the last quarter. Ballentine Partners LLC acquired a new position in shares of Alignment Healthcare in the 4th quarter valued at $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Alignment Healthcare in the 3rd quarter valued at $131,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.